Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion type Assertion NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_head.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion description "[We determined the frequencies of three LPL polymorphisms (D9N, N291S, and S447X) in 899 men from the Veterans Affairs HDL Intervention Trial (VA-HIT), a study that examined the potential benefits of increasing HDL with gemfibrozil in men with established CHD and low high density lipoprotein cholesterol (HDL-C; < or =40 mg/dl), and compared them with those of men without CHD from the Framingham Offspring Study (FOS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_provenance.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion evidence source_evidence_literature NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_provenance.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion SIO_000772 15292370 NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_provenance.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion wasDerivedFrom befree-20140225 NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_provenance.
- NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_assertion wasGeneratedBy ECO_0000203 NP280704.RA1xT5_znHNmssq9gRHb-FmyO0eSMP1CYQAJ4T7yLhqK0130_provenance.